Barflex Polyfilm (BARFLEX)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹59.9 |
| Market Cap | ₹148.37 Cr |
| P/E Ratio | 12.37 |
| ROCE | 13.34% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -49.02% |
| Debt/Equity | — |
| Sales Growth | 4.37% |
| Promoter Holding | 67.22% |
| 52-Week Range | ₹50.05 — ₹67.5 |
| Sector | Industrial Products |
Strengths
- ROCE of 13.34% shows acceptable capital efficiency in a competitive packaging sector.
- Promoter holding of 67.22% aligns management with minority shareholders.
- Latest quarter net profit of ₹4 Cr on sales of ₹51 Cr implies a solid 7.8% net margin.
- Trailing P/E of 12.37 and market cap of ₹148 Cr offer a modest, not expensive, valuation.
- Current price of ₹59.90 is near the lower end of the 52-week range (₹50.05-₹67.50).
Concerns
- Profit growth of -49.02% signals a major earnings setback; trailing profits may not be repeatable.
- Piotroski F-Score of 4/9 points to worsening underlying financials.
- Sales growth of only 4.37% means the company is not expanding meaningfully.
- Zero dividend yield and missing book value/debt data reduce transparency for a retail investor.
AI Analysis
Let me apply the Graham-Buffett lens to Barflex Polyfilm. Packaging is a necessary industry, but necessary doesn't mean profitable. Sales growth of just 4.37% over the trailing period is pedestrian. More troubling, profit is down 49% year-over-year. A 12.37 P/E on declining earnings isn't a bargain; it's a value trap unless operations stabilize. ROCE at 13.34% is respectable but not exceptional, and the Piotroski F-score of 4/9 tells me the financial health is deteriorating — poor profitability, leverage, or efficiency signals. At the current price of ₹59.90, market cap is ₹148 crore, implying trailing earnings of about ₹12 crore. The latest quarter's ₹4 crore net profit on ₹51 crore sales is a bright spot, a 7.8% margin, but one quarter doesn't make a trend. There is no dividend to cushion the wait. Promoter holding of 67.22% is a positive — skin in the game — but without book value or debt/equity data I cannot assess the balance sheet risk. A 2.83 PEG, based on sales growth, doesn't justify the price if earnings continue to fall. When profit growth is negative, I demand a margin of safety. Here I don't see one. Barflex may have decent capital returns, but a 4/9 F-score and no clear catalyst mean I'd rather watch from the sidelines until earnings stabilise and more data is disclosed.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer